Treatment Advances and KDIGO Guidelines Shape IgA Nephropathy Care
Sparsentan Reduces Proteinuria in IgA Nephropathy
FDA Approves Atrasentan for IgA Nephropathy Proteinuria
This week's must-know community updates, latest research & events
Apply now: feature your voice in our cell and gene therapy series
O. felineus Infection Impacts Kidney Function
Felzartamab Reduces Proteinuria in IgA Nephropathy
Metabolic Syndrome Linked to Poor Outcomes in Kidney Disease Patients
Alebund's New Funding Boosts Hope for Kidney Disease Treatments Globally
Innovative Treatments and Hopeful Advances in IgA Nephropathy Management
